These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2173472)

  • 21. Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.
    Dong L; Masaki Y; Takegami T; Kawanami T; Itoh K; Jin ZX; Huang CR; Tong XP; Fukushima T; Tanaka M; Sawaki T; Sakai T; Sugai S; Okazaki T; Hirose Y; Umehara H
    Int Immunol; 2007 Mar; 19(3):331-6. PubMed ID: 17272286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of O6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma.
    Sagher D; Karrison T; Schwartz JL; Larson RA; Strauss B
    Cancer Res; 1989 Oct; 49(19):5339-44. PubMed ID: 2548719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers.
    Masucci MG; Szigeti R; Ernberg I; Björkholm M; Mellstedt H; Henle G; Henle W; Pearson G; Masucci G; Svedmyr E; Johansson B; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4292-301. PubMed ID: 6272973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.
    Mueller N; Evans A; Harris NL; Comstock GW; Jellum E; Magnus K; Orentreich N; Polk BF; Vogelman J
    N Engl J Med; 1989 Mar; 320(11):689-95. PubMed ID: 2537928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
    Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
    Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
    Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
    Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus in Reed-Sternberg-like cells in non-Hodgkin's lymphomas.
    Khan G; Norton AJ; Slavin G
    J Pathol; 1993 Jan; 169(1):9-14. PubMed ID: 8381864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses.
    Libra M; Gloghini A; De Re V; Rupolo M; Navolanic PM; Gasparotto D; Stivala F; Spina M; Boiocchi M; Carbone A
    Int J Oncol; 2005 Apr; 26(4):945-50. PubMed ID: 15753988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
    Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
    J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
    Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
    Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between Epstein-Barr virus and lymphoproliferative syndromes in patients without immunodeficiency].
    Barranco M; Vidal J; Quintero L; Vives-Corrons JL; Jiménez de Anta MT
    Sangre (Barc); 1995 Oct; 40(5):383-7. PubMed ID: 8553172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of Epstein-Barr virus in lymphoproliferative diseases by in situ hybridization].
    Xia C; Liu F; Sun Y
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):267-9. PubMed ID: 11038755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against herpesviruses in patients with Hodgkin's disease.
    Wutzler P; Färber I; Sprössig M; Sauerbrei A; Wutke K; Höche D; Rüdiger KD; Wöckel W; Scheibner K
    Arch Geschwulstforsch; 1983; 53(5):417-22. PubMed ID: 6316868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease.
    Lange B; Arbeter A; Hewetson J; Henle W
    Int J Cancer; 1978 Nov; 22(5):521-7. PubMed ID: 82539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.